Latest filing published 22 Feb 2024 for Theravance Biopharma, Inc., €160k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Richard A. Graham: trading record in brief
This profile gathers the share dealings of Richard A. Graham in Theravance Biopharma, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 20 August 2020 to 20 February 2024, the count stands at 35 filings.
No open-market purchase appears, only 14 sales worth €544k. The rest of the record consists of 21 share grants.
The record was last updated on 22 February 2024 with a share grant (€160k) in Theravance Biopharma, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Richard A. Graham
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,294 shares@ US$8.927.8% of flowOrdinary SharesSEC:0001415889-24-004960:0
- 12,630 shares@ US$10.375.9% of flowOrdinary SharesSEC:0001415889-23-015448:0
- 2,482 shares@ US$10.221.2% of flowOrdinary SharesSEC:0001415889-23-015228:0
- 15,000 shares0Ordinary SharesSEC:0001415889-23-014680:0
- 2,482 shares@ US$9.031.0% of flowOrdinary SharesSEC:0001415889-23-014412:0
- 2,482 shares@ US$9.891.2% of flowOrdinary SharesSEC:0001415889-23-013342:0
- 10,461 shares@ US$9.704.6% of flowOrdinary SharesSEC:0001415889-23-012514:0
- 2,322 shares@ US$9.991.0% of flowOrdinary SharesSEC:0001415889-23-012271:0
- 2,322 shares@ US$9.841.0% of flowOrdinary SharesSEC:0001415889-23-011244:0
- 2,322 shares@ US$10.691.1% of flowOrdinary SharesSEC:0001415889-23-009963:0
- 10,460 shares@ US$11.215.3% of flowOrdinary SharesSEC:0001415889-23-008670:0
- 2,322 shares@ US$11.261.2% of flowOrdinary SharesSEC:0001415889-23-008228:0
- 2,323 shares@ US$11.881.2% of flowOrdinary SharesSEC:0001415889-23-006620:0
- 2,323 shares@ US$10.321.1% of flowOrdinary SharesSEC:0001415889-23-005044:0
- 2,323 shares@ US$10.051.1% of flowOrdinary SharesSEC:0001415889-23-004552:0
- 75,000 shares0Ordinary SharesSEC:0001415889-23-004271:0
- 12,057 shares@ US$10.445.8% of flowOrdinary SharesSEC:0001415889-23-003065:0
- 2,084 shares@ US$10.731.0% of flowOrdinary SharesSEC:0001415889-22-012077:0
- 27,350 shares@ US$10.8514.0% of flowOrdinary SharesSEC:0001415889-22-011669:0
- 2,800 shares@ US$11.201.5% of flowOrdinary SharesSEC:0001415889-22-011523:0
- 18,991 shares@ US$9.348.6% of flowOrdinary SharesSEC:0001415889-22-008981:0
- 4,906 shares@ US$9.71052.3% of flowOrdinary SharesSEC:0001415889-22-008835:0
- 15,086 shares@ US$8.796.3% of flowOrdinary SharesSEC:0001415889-22-008512:0
- 3,947 shares@ US$8.740.0039% mcap6.1% of flowOrdinary SharesSEC:0001415889-22-005629:0
- 20,377 shares@ US$9.619.1% of flowOrdinary SharesSEC:0001415889-22-001697:0
25 of 29 declarations
